Showing 1 - 10 of 28
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing...
Persistent link: https://www.econbiz.de/10011395349
Persistent link: https://www.econbiz.de/10002523628
Persistent link: https://www.econbiz.de/10003336419
Persistent link: https://www.econbiz.de/10003810136
Persistent link: https://www.econbiz.de/10003939923
Persistent link: https://www.econbiz.de/10008732288
"On January 1, 2006, the federal government began providing insurance coverage for Medicare recipients' prescription drug expenditures through a new program known as Medicare Part D. Rather than setting pharmaceutical prices itself, the government contracted with private insurance plans to...
Persistent link: https://www.econbiz.de/10003687797
Persistent link: https://www.econbiz.de/10009266609
Persistent link: https://www.econbiz.de/10010257891
Persistent link: https://www.econbiz.de/10011436798